# BTS: a scalable Bayesian Tissue Score for prioritizing GWAS variants and their functional contexts across >1000s of omics datasets

**Authors:** Pavel P Kuksa, Matei Ionita, Luke Carter, Jeffrey Cifello, Prabhakaran Gangadharan, Kaylyn Clark, Otto Valladares, Yuk Yee Leung, Li-San Wang

PMC · DOI: 10.1093/bioinformatics/btaf509 · Bioinformatics · 2025-09-26

## TL;DR

BTS is a new algorithm that efficiently identifies cell types and genomic features linked to genetic variants in diseases using large genomic datasets.

## Contribution

BTS introduces a scalable Bayesian method for context-specific fine-mapping and annotation prioritization in GWAS analyses.

## Key findings

- BTS is over 100× more efficient than existing methods in estimating functional annotation effects.
- BTS identifies both known and novel annotations, cell types, and genomic regions linked to immune and cardiovascular diseases.
- The method provides biological insights into disease-related functional contexts using diverse genomic datasets.

## Abstract

Summary statistics from genome-wide association studies (GWAS) are widely used in fine-mapping and colocalization analyses to identify causal variants and their enrichment in functional contexts, such as affected cell types and genomic features. With the expansion of functional genomic (FG) datasets, which now include hundreds of thousands of tracks across various cell and tissue types, it is critical to establish scalable algorithms integrating thousands of diverse FG annotations with GWAS results.

We propose BTS (Bayesian Tissue Score), a novel, highly efficient algorithm uniquely designed for (i) identifying affected cell types and functional elements (context-mapping) and (ii) fine-mapping potentially causal variants in a context-specific manner using large collections of cell type-specific FG annotation tracks. BTS leverages GWAS summary statistics and annotation-specific Bayesian models to analyze genome-wide annotation tracks, including enhancers, open chromatin, and histone marks. We evaluated BTS on GWAS summary statistics for immune and cardiovascular traits, such as Inflammatory Bowel Disease (IBD), Rheumatoid Arthritis (RA), Systemic Lupus Erythematosus (SLE), and Coronary Artery Disease (CAD). Our results demonstrate that BTS is over 100× more efficient in estimating functional annotation effects and context-specific variant fine-mapping compared to existing methods. Importantly, this large-scale Bayesian approach prioritizes both known and novel annotations, cell types, genomic regions, and variants and provides valuable biological insights into the functional contexts of these diseases.

Docker image is available at https://hub.docker.com/r/wanglab/bts with preinstalled BTS R package (https://bitbucket.org/wanglab-upenn/BTS-R) and BTS GWAS summary statistics analysis pipeline (https://bitbucket.org/wanglab-upenn/bts-pipeline).

## Linked entities

- **Diseases:** Inflammatory Bowel Disease (MONDO:0005265), Rheumatoid Arthritis (MONDO:0008383), Systemic Lupus Erythematosus (MONDO:0007915), Coronary Artery Disease (MONDO:0005010)

## Full-text entities

- **Diseases:** CAD (MESH:D003324), IBD (MESH:D015212), SLE (MESH:D008180), RA (MESH:D001172)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12517339/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12517339/full.md

## References

67 references — full list in the complete paper: https://tomesphere.com/paper/PMC12517339/full.md

---
Source: https://tomesphere.com/paper/PMC12517339